Design and synthesis of potent and subtype-selective PPARα agonists

被引:18
作者
Desai, RC
Metzger, E
Santini, C
Meinke, PT
Heck, JV
Berger, JP
MacNaul, KL
Cai, TQ
Wright, SD
Agrawal, A
Moller, DE
Sahoo, SP
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Cardiovasc Dis, Rahway, NJ 07065 USA
[4] Merck Res Labs, Dept Drug Metab, Rahway, NJ 07065 USA
关键词
PPAR alpha agonist;
D O I
10.1016/j.bmcl.2005.12.022
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Beginning with a moderately potent PPAR gamma agonist 9, a series of potent and highly subtype-selective PPAR alpha agonists was identified through a systematic SAR study. Based on the results of the efficacy studies in the hamster and dog models of dyslipidemia and the desired pharmacokinetic data, the optimized compound 39 was selected for further profiling. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1673 / 1678
页数:6
相关论文
共 14 条
[1]   Amphipathic 3-phenyl-7-propylbenziscoxazoles;: human PPaR γ, δ and α agonists [J].
Adams, AD ;
Yuen, W ;
Hu, Z ;
Santini, C ;
Jones, AB ;
MacNaul, KL ;
Berger, JP ;
Doebber, TW ;
Moller, DE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (05) :931-935
[2]   Hypercholesterolemia and coronary heart disease in the elderly: A meta-analysis [J].
Anum, EA ;
Adera, T .
ANNALS OF EPIDEMIOLOGY, 2004, 14 (09) :705-721
[3]   Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects [J].
Berger, J ;
Leibowitz, MD ;
Doebber, TW ;
Elbrecht, A ;
Zhang, B ;
Zhou, GC ;
Biswas, C ;
Cullinan, CA ;
Hayes, NS ;
Li, Y ;
Tanen, M ;
Ventre, J ;
Wu, MS ;
Berger, GD ;
Mosley, R ;
Marquis, R ;
Santini, C ;
Sahoo, SP ;
Tolman, RL ;
Smith, RG ;
Moller, DE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6718-6725
[4]   A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARα agonist with potent lipid-lowering activity [J].
Brown, PJ ;
Winegar, DA ;
Plunket, KD ;
Moore, LB ;
Lewis, MC ;
Wilson, JG ;
Sundseth, SS ;
Koble, CS ;
Wu, ZD ;
Chapman, JM ;
Lehmann, JM ;
Kliewer, SA ;
Willson, TM .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (19) :3785-3788
[5]   Identification of a subtype selective human PPARα agonist through parallel-array synthesis [J].
Brown, PJ ;
Stuart, LW ;
Hurley, KP ;
Lewis, MC ;
Winegar, DA ;
Wilson, JG ;
Wilkinson, WO ;
Ittoop, OR ;
Willson, TM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (09) :1225-1227
[6]   Aryloxazolidinediones:: Identification of potent orally active PPAR dual α/γ agonists [J].
Desai, RC ;
Gratale, DF ;
Han, W ;
Koyama, H ;
Metzger, E ;
Lombardo, VK ;
MacNaul, KL ;
Doebber, TW ;
Berger, JP ;
Leung, K ;
Franklin, R ;
Moller, DE ;
Heck, JV ;
Sahoo, SP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (20) :3541-3544
[7]   5-aryl thiazolidine-2,4-diones:: Discovery of PPAR dual α/γ agonists as antidiabetic agents [J].
Desai, RC ;
Han, W ;
Metzger, EJ ;
Bergman, JP ;
Gratale, DF ;
MacNaul, KL ;
Berger, JP ;
Doebber, TW ;
Leung, K ;
Moller, DE ;
Heck, JV ;
Sahoo, SP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (16) :2795-2798
[8]  
DESAI RC, 2004, Patent No. 2004010992
[9]   (2R)-2-Methylchromane-2-carboxylic acids:: Discovery of selective PPARα agonists as hypolipidemic agents [J].
Koyama, H ;
Boueres, JK ;
Miller, DJ ;
Berger, JP ;
MacNaul, KL ;
Wang, PR ;
Ippolito, MC ;
Wright, SD ;
Agrawal, AK ;
Moller, DE ;
Sahoo, SP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (14) :3347-3351
[10]   Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor a subtype-selective activators [J].
Nomura, M ;
Tanase, T ;
Ide, T ;
Tsunoda, M ;
Suzuki, M ;
Uchiki, H ;
Murakami, K ;
Miyachi, H .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (17) :3581-3599